Under the agreement, GoodRx will acquire the platform from TherapeuticsMD for $150 million, with an additional $7 million consideration contingent upon its financial performance through 2023.
The platform is designed to help patients understand their coverage and find savings opportunities for brand medications.
“Over the past decade, GoodRx has helped millions of Americans afford generic medications, but brand medications remain too expensive for too many people,” Doug Hirsch, co-CEO and co-founder of GoodRx, said in a March 7 news release. “With VitaCare, we aim to grow our reach and provide new tools for both consumers and providers to help ensure that more patients can access relevant savings programs and navigate prior authorization requirements.”
The deal is expected to close in mid-2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
